SCHEMBL5589047

SCHEMBL5589047

CCCc1cc(O)c(O)c(CCC)c1CCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 1/20 0.42
PGAM1 P18669 1/20 0.41
ALOX5 P09917 5/20 0.40
PTPN1 P18031 3/20 0.39
PRKCI P41743 1/20 0.39
PTPN11 Q06124 1/20 0.39
MAPK1 P28482 3/20 0.36
HTT P42858 2/20 0.36
NPC1 O15118 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
MEN1 O00255 4/20 0.35
RECQL P46063 4/20 0.35
KMT2A Q03164 4/20 0.35
TDP1 Q9NUW8 4/20 0.35
APEX1 P27695 3/20 0.35
THRB P10828 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5676243 0.92 HTT (0.48) HMGCRPGAM1ALOX5PTPN1PRKCI
SCHEMBL5676592 0.89 PGAM1 (0.43) HMGCRPGAM1ALOX5PTPN1PRKCI
SCHEMBL5920126 0.88 HTT (0.48) PGAM1ALOX5MAPK1HTTNPC1
SCHEMBL5680781 0.87 ALOX5 (0.53) ALOX5MAPK1HTTNPC1HPGD
SCHEMBL5676568 0.85 ALOX5 (0.51) ALOX5MAPK1HTTNPC1HPGD
SCHEMBL5677867 0.85 ALOX5 (0.51) ALOX5MAPK1HTTNPC1HPGD
SCHEMBL5676100 0.85 ALOX5 (0.51) ALOX5MAPK1HTTNPC1HPGD
SCHEMBL31633427 0.84 HMGCR (0.44) HMGCRALOX5PTPN1PRKCIPTPN11
SCHEMBL4806602 0.84 HMGCR (0.44) HMGCRALOX5PTPN1PRKCIPTPN11
SCHEMBL27545397 0.83 HTT (0.52) ALOX5MAPK1HTTNPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 HMGCR 3000/4885PGAM1 1128/4885ALOX5 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.